Skip to main content

Table 3 Characteristics of insulin and oral antidiabetic medication use among patients, by country

From: Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)

 

All patients N = 4,341

China N = 373

GermanyN = 149

India N = 918

Mexico N = 206

Russia N = 240

Saudi Arabia N = 226

USA N = 540

 

N (%)

Any insulin regimen together with:

        

 0 oral antidiabetic drugs

1449 (33)

203 (54)

90 (60)

161 (18)

120 (58)

127 (53)

56 (25)

149 (28)

 1 oral antidiabetic drug

1388 (32)

109 (29)

41 (28)

243 (27)

58 (28)

69 (29)

41 (18)

224 (41)

 2 oral antidiabetic drugs

977 (23)

52 (14)

14 (9)

282 (31)

21 (10)

37 (15)

78 (35)

132 (24)

 3 or more oral antidiabetic drugs

527 (12)

9 (2)

4 (3)

232 (25)

7 (3)

7 (3)

51 (23)

35 (6)

Insulin regimen

        

 Basal insulin only

2234 (51)

60 (16)

65 (44)

252 (27)

146 (71)

197 (82)

140 (62)

355 (66)

 Basal + short-acting insulin only

237 (5)

3 (1)

6 (4)

11 (1)

15 (7)

13 (5)

1 (0)

32 (6)

 Mixed insulin only

1310 (30)

249 (67)

66 (44)

522 (57)

34 (17)

19 (8)

40 (18)

93 (17)

 Short-acting insulin only

175 (4)

13 (4)

5 (3)

43 (5)

9 (4)

10 (4)

0 (0)

20 (4)

 Other insulin combinations

385 (9)

48 (13)

7 (5)

90 (10)

2 (1)

1 (0)

45 (20)

40 (7)

Insulin injection frequency

        

 Once per day

2579 (59)

128 (34)

80 (54)

415 (45)

152 (74)

161 (67)

147 (65)

373 (69)

 Twice per day

1585 (37)

220 (59)

58 (39)

494 (54)

51 (25)

77 (32)

78 (35)

144 (27)

 Three times per day

177 (4)

25 (7)

11 (7)

9 (1)

3 (2)

2 (1)

1 (0)

23 (4)

Insulin delivery device

        

 Pen

3220 (74)

372 (100)

141 (95)

541 (59)

67 (33)

220 (93)

142 (63)

243 (45)

 Syringe

1109 (26)

1 (0)

8 (5)

373 (41)

138 (68)

17 (7)

84 (37)

296 (55)